Primary and secondary prevention of coronary heart disease. Evidence offers multiple strategies.
Lynn
M M
MM
Veterans Affairs Medical Center, Denver, USA.
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D008078:Cholesterol, LDL / Q000097:blood; D003327:Coronary Disease / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000517:prevention & control; D019317:Evidence-Based Medicine; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000150:complications / Q000517:prevention & control; D006973:Hypertension / Q000150:complications / Q000517:prevention & control; D009722:Nurse Practitioners; D009765:Obesity / Q000150:complications / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D011320:Primary Health Care / Q000379:methods; D011322:Primary Prevention / Q000379:methods*; D012307:Risk Factors; D040242:Risk Reduction Behavior; D012907:Smoking / Q000009:adverse effects; D000074606:Smoking Prevention
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors